Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma

This study has been completed.
Sponsor:
Information provided by:
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT00135187
First received: August 23, 2005
Last updated: February 5, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)